Skip to main navigation Skip to search Skip to main content

Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for alzheimer disease

  • Hillary D. Protas
  • , Kewei Chen
  • , Jessica B.S. Langbaum
  • , Adam S. Fleisher
  • , Gene E. Alexander
  • , Wendy Lee
  • , Daniel Bandy
  • , Mony J. De Leon
  • , Lisa Mosconi
  • , Shannon Buckley
  • , Diana Truran-Sacrey
  • , Norbert Schuff
  • , Michael W. Weiner
  • , Richard J. Caselli
  • , Eric M. Reiman

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To characterize and compare measurements of the posterior cingulate glucose metabolism, the hippocampal glucose metabolism, and hippocampal volume so as to distinguish cognitively normal, late-middleaged persons with 2, 1, or 0 copies of the apolipoprotein E (APOE) e4 allele, reflecting 3 levels of risk for lateonset Alzheimer disease. Design: Cross-sectional comparison of measurements of cerebral glucose metabolism using 18F-fluorodeoxyglucose positron emission tomography and measurements of brain volume using magnetic resonance imaging in cognitively normal e4 homozygotes, e4 heterozygotes, and noncarriers. Setting: Academic medical center. Participants: A total of 31 e4 homozygotes, 42 e4 heterozygotes, and 76 noncarriers, 49 to 67 years old, matched for sex, age, and educational level. Main Outcome Measures: The measurements of posterior cingulate and hippocampal glucose metabolism were characterized using automated region-of-interest algorithms and normalized for whole-brain measurements. The hippocampal volume measurements were characterized using a semiautomated algorithm and normalized for total intracranial volume. Results: Although there were no significant differences among the 3 groups of participants in their clinical ratings, neuropsychological test scores, hippocampal volumes (P=.60), or hippocampal glucose metabolism measurements (P = .12), there were significant group differences in their posterior cingulate glucose metabolism measurements (P=.001). The APOE e4 gene dose was significantly associated with posterior cingulate glucose metabolism (r=0.29, P=.0003), and this association was significantly greater than those with hippocampal volume or hippocampal glucose metabolism (P<.05, determined by use of pairwise Fisher z tests). Conclusions: Although our findings may depend in part on the analysis algorithms used, they suggest that a reduction in posterior cingulate glucose metabolism precedes a reduction in hippocampal volume or metabolism in cognitively normal persons at increased genetic risk for Alzheimer disease.

Original languageEnglish (US)
Pages (from-to)320-325
Number of pages6
JournalJAMA Neurology
Volume70
Issue number3
DOIs
StatePublished - Mar 2013

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for alzheimer disease'. Together they form a unique fingerprint.

Cite this